← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

▼ SELL

$ Value

$19K

Shares

3,016

Price

$6

Filed

Feb 20

Insider

Name

Otero Jose Manuel

Title

Chief Operating Officer

CIK

0002024096

Roles

Officer

Transaction Details

Transaction Date

2026-02-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

125,460

Footnotes

Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs"). | This transaction was executed in multiple trades at prices ranging from $6.22 to $6.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Includes 104,216 Restricted Stock Units.

Filing Info

Accession No.

0002024096-26-000005

Form Type

4

Issuer CIK

0001907108

Otero Jose Manuel's History

Date Ticker Type Value
2026-02-18 LXEO $19K
2026-02-04 LXEO A $0
2026-02-04 LXEO A $0
2025-11-18 LXEO $7K
2025-10-17 LXEO $19K
2025-10-17 LXEO $229
2025-10-15 LXEO A $0
2025-08-18 LXEO $13K
2025-08-18 LXEO $7K

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$378K 2026-04-06
Otero Jose Manuel
Chief Operating Officer
$7K 2026-02-04
Tamayo Louis Edward
Chief Financial Officer
2026-02-04
Bhalla Narinder Pal
Chief Medical Officer
2026-02-13